The Key Pathway Targets for Longevity Drugs (new paper)

This seems to confirm some of the most common pathways we know about: MTOR, AMPK, IGF/GH, TERT, FGF, but some new ones to pay attention to also…

Candidate molecular targets uncovered in mouse lifespan extension studies

Expert opinion

To increase the translational potential of mice life-extension studies to clinical research several factors are crucial: standardization of mice lifespan research approaches, the development of clear criteria for control and experimental groups, the establishment of criteria for potential geroprotectors, and focusing on targets and their clinical application. Pinpointing the targets affected by geroprotectors helps in understanding species-specific differences and identifying potential side effects, ensuring the safety and effectiveness of clinical trials. Additionally, target review facilitates the optimization of treatment protocols and the evaluation of the clinical feasibility of translating research findings into practical therapies for humans.

Paywalled Paper:

https://www.tandfonline.com/doi/full/10.1080/14728222.2024.2346597

2 Likes

The pathways to better mitochondria and fewer senescent cells.

I wonder why GSK3 didn’t make the list? I think there is at least one paper tying GSK3 inhibition to >10% lifespan extension.